ZBTB7 overexpression contributes to malignancy in breast cancer

Cancer Investigation

Volumn 28, Issue 6, 2010, Pages 672-678

  Qu, Hongyan ^a   Qu, Danni ^b   Chen, Fuhui ^a   Zhang, Zhenyu ^b   Liu, Baogang ^a   Liu, Haifeng ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; BTB POZ; ZBTB7

Indexed keywords

ESTROGEN RECEPTOR; ONCOPROTEIN; PROTEIN ZBTB7; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST SURGERY; CANCER GRADING; CANCER PATIENT; CANCER TISSUE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE AMPLIFICATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; DNA-BINDING PROTEINS; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN; RECURRENCE; RISK ASSESSMENT; TIME FACTORS; TRANSCRIPTION FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 77953206108     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357901003631007     Document Type: Article

References (25)

1. Pessler, F.; Pendergrast, P.S.; Hernandez, N. Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts. Mol Cell Biol 1997, 17(7), 3786-3798.
2. Kukita, A.; Kukita, T.; Ouchida, M.; Maeda, H.; Yatsuki, H.; Kohashi, O. Osteoclast-derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis. Blood 1999, 94(6), 1987-1997.
3. Davies, J.M.; Hawe, N.; Kabarowski, J.; Huang, Q.H.; Zhu, J.; Brand, N.J.; Leprince, D.; Dhordain, P.; Cook, M.; Morriss-Kay, G.; Zelent, A. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene. Oncogene 1999, 18(2), 365-375.
4. Maeda, T.; Hobbs, R.M.; Merghoub, T.; Guernah, I.; Zelent, A.; Cordon-Cardo, C.; Teruya-Feldstein, J.; Pandolfi, P.P. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 2005, 433(7023), 278-285.
5. Huynh, K.D.; Fischle, W.; Verdin, E.; Bardwell, V.J. BCoR, a novel corepressor involved in BCL-6 repression. Gene Dev 2000, 14(14), 1810-1823.
6. Wong, C.W.; Privalsky, M.L. Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6. J Biol Chem 1998, 273(42), 27695-27702.
7. David, G.; Alland, L.; Hong, S.H.; Wong, C.W.; DePinho, R.A.; Dejean, A. Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein. Oncogene 1998, 16(19), 2549-2556.
8. Dhordain, P.; Lin, R.J.; Quief, S.; Lantoine, D.; Kerckaert, J.P.; Evans, R.M.; Albagli, O. The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression. Nucleic Acids Res 1998, 26(20), 4645-4651.
9. Molnar, A.; Georgopoulos, K. The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol Cell Biol 1994, 14(12), 8292-8303.
10. Sun, L.; Liu, A.; Georgopoulos, K. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J 1996, 15(19), 5358-5369.
11. Schubot, F.D.; Tropea, J.E.; Waugh, D.S. Structure of the POZ domain of human LRF, a master regulator of oncogenesis. Biochem Biophys Res Commun 2006, 351(1), 1-6.
12. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25(4), 402-408.
13. Hiyama, K.; Kodaira, M.; Satoh, C. Detection of deletions, insertions and single nucleotide substitutions in cloned beta-globin genes and new polymorphic nucleotide substitutions in beta-globin genes in a Japanese population using ribonuclease cleavage at mismatches in RNA:DNA duplexes. Mutat Res 1990, 231(2), 219-231.
14. Zhao, Z.H.; Wang, S.F.; Yu, L.; Wang, J.; Chang, H.; Yan, W.L.; Fu, K.; Zhang, J. Expression of transcription factor Pokemon in non-small cell lung cancer and its clinical significance. Chin Med J (Engl) 2008, 121(5), 445-449.
15. Apostolopoulou, K.; Pateras, I.S.; Evangelou, K.; Tsantoulis, P.K.; Liontos, M.; Kittas, C.; Tiniakos, D.G.; Kotsinas, A.; Cordon-Cardo, C.; Gorgoulis, V.G. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer. J Pathol 2007, 213(3), 294-302.
16. Maeda, T.; Hobbs, R.M.; Pandolfi, P.P. The transcription factor Pokemon: a new key player in cancer pathogenesis. Cancer Res 2005, 65(19), 8575-8578.
17. Ishibashi, M.; Nakayama, K.; Yeasmin, S.; Katagiri, A.; Iida, K.; Nakayama, N.; Fukumoto, M.; Miyazaki, K. A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a potential target for taxol resistance in ovarian cancer. Clin Cancer Res 2008, 14(10), 3149-3155.
18. Ishibashi, M.; Nakayama, K.; Yeasmin, S.; Katagiri, A.; Iida, K.; Nakayama, N.; Miyazaki, K. Expression of a BTB/POZ protein, NAC1, is essential for the proliferation of normal cyclic endometrial glandular cells and is up-regulated by estrogen. Clin Cancer Res 2009, 15(3), 804-811.
19. Nakayama, K.; Nakayama, N.; Davidson, B.; Sheu, J.J.; Jinawath, N.; Santillan, A.; Salani, R.; Bristow, R.E.; Morin, P.J.; Kurman, R.J.; Wang, T.L.; Shih, I.M. A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival. Proc Natl Acad Sci USA 2006, 103(49), 18739-18744.
20. Astier, A.L.; Xu, R.; Svoboda, M.; Hinds, E.; Munoz, O.; de, B.R.; Crean, C.D.; Gabig, T.; Freedman, A.S. Temporal gene expression profile of human precursor B leukemia cells induced by adhesion receptor: identification of pathways regulating B-cell survival. Blood 2003, 101(3), 1118-1127.
21. Zhao, Z.H.; Wang, S.F.; Yu, L.; Wang, J.; Chang, H.; Yan, W.L.; Zhang, J.; Fu, K. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Lung Cancer 2008, 62(1), 113-119.
22. Komori, H.; Enomoto, M.; Nakamura, M.; Iwanaga, R.; Ohtani, K. Distinct E2F-mediated transcriptional program regulates p14ARF gene expression. EMBO J 2005, 24(21), 3724-3736.
23. Godolphin, W.; Elwood, J.M.; Spinelli, J.J. Estrogen receptor quantitation and staging as complementary prognostic indicators in breast cancer: a study of 583 patients. Int J Cancer 1981, 28(6), 677-683.
24. Shek, L.L.; Godolphin, W. Survival with breast cancer: the importance of estrogen receptor quantity. Eur J Cancer Clin Oncol 1989, 25(2), 243-250.
25. Polo, J.M.; Dell, O.T.; Ranuncolo, S.M.; Cerchietti, L.; Beck, D.; Da, S.G.; Prive, G.G.; Licht, J.D.; Melnick, A. Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells. Nat Med 2004, 10(12), 1329-1335.